RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28574596http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28574596http://www.w3.org/2000/01/rdf-schema#comment"GPR84, a member of the G protein-coupled receptor family, is found predominantly in immune cells, such as macrophages, and functions as a pivotal modulator of inflammatory responses. In this study, we investigated the role of GPR84 in receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation. Our microarray data showed that GPR84 was significantly downregulated in osteoclasts compared to in their precursors, macrophages. The overexpression of GPR84 in bone marrow-derived macrophages suppressed the formation of multinucleated osteoclasts without affecting precursor proliferation. In addition, GPR84 overexpression attenuated the induction of c-Fos and nuclear factor of activated T cells, cytoplasmic 1 (NFATc1), which are transcription factors that are critical for osteoclastogenesis. Furthermore, knockdown of GPR84 using a small hairpin RNA promoted RANKL-mediated osteoclast differentiation and gene expression of osteoclastogenic markers. Mechanistically, GPR84 overexpression blocked RANKL-stimulated phosphorylation of IκBα and three MAPKs, JNK, ERK, and p38. GPR84 also suppressed NF-κB transcriptional activity mediated by RANKL. Conversely, GPR84 knockdown enhanced RANKL-induced activation of IκBα and the three MAPKs. Collectively, our results revealed that GPR84 functions as a negative regulator of osteoclastogenesis, suggesting that it may be a potential therapeutic target for osteoclast-mediated bone-destructive diseases."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.org/dc/terms/identifier"doi:10.1002/jcp.26035"xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Kim H.J."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Lee H.W."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Yoon H.J."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Cho S."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Park J.W."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Kang W.Y."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Seong S.J."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/author"Yoon Y.R."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/name"J Cell Physiol"xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/pages"1481-1489"xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/title"G protein-coupled receptor 84 controls osteoclastogenesis through inhibition of NF-kappaB and MAPK signaling pathways."xsd:string
http://purl.uniprot.org/citations/28574596http://purl.uniprot.org/core/volume"233"xsd:string
http://purl.uniprot.org/citations/28574596http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28574596
http://purl.uniprot.org/citations/28574596http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28574596
http://purl.uniprot.org/uniprot/#_A0A0R4J100-mappedCitation-28574596http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28574596
http://purl.uniprot.org/uniprot/#_Q8CIM5-mappedCitation-28574596http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28574596
http://purl.uniprot.org/uniprot/A0A0R4J100http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28574596
http://purl.uniprot.org/uniprot/Q8CIM5http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28574596